NCT05674786View on ClinicalTrials.gov

Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction

NARecruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

March 31, 2027

Conditions
Other Disorders of Vestibular Function, BilateralBilateral Vestibular Deficiency (BVD)Gentamicin OtotoxicityLabyrinth DiseasesVestibular DiseasesSensation DisordersBilateral Vestibular HypofunctionBilateral VestibulopathyAminoglycoside Ototoxicity
Interventions
DEVICE

Labyrinth Devices MVI™ Multichannel Vestibular Implant System

Unilateral implantation of a Labyrinth Devices MVI™ Multichannel Vestibular Implant System receiver/stimulator including insertion of electrode arrays in the semicircular canal ampullae of the inner ear, followed by motion-modulated prosthetic electrical stimulation.

Trial Locations (1)

21287

RECRUITING

Johns Hopkins School of Medicine, Baltimore

All Listed Sponsors
collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

collaborator

Labyrinth Devices, LLC

OTHER

lead

Johns Hopkins University

OTHER